Associated Papers
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Miyazaki I et al.
Nature Cancer, 2023
37743366 (PubMed )
Supplement: 43018_2023_630_MOESM3_ESM.xlsx › Supplementary_Table_2
Select a paper to view details